SLI
1.984,39
PKT
-17,19
PKT
-0,86
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 20.03.20 | Novartis Hold | Deutsche Bank AG | |
| 20.03.20 | Roche buy | Deutsche Bank AG | |
| 19.03.20 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 19.03.20 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 19.03.20 | UBS Sector Perform | RBC Capital Markets | |
| 19.03.20 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 18.03.20 | Givaudan Underweight | Morgan Stanley | |
| 18.03.20 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 18.03.20 | Nestlé Hold | Jefferies & Company Inc. | |
| 17.03.20 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
| 17.03.20 | Nestlé overweight | JP Morgan Chase & Co. | |
| 17.03.20 | Roche overweight | Barclays Capital | |
| 17.03.20 | Novartis Underweight | Barclays Capital | |
| 17.03.20 | UBS Sector Perform | RBC Capital Markets | |
| 17.03.20 | UBS Sector Perform | RBC Capital Markets | |
| 17.03.20 | Nestlé overweight | Barclays Capital | |
| 13.03.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 13.03.20 | ams-OSRAM verkaufen | Credit Suisse Group | |
| 13.03.20 | Givaudan Underperform | Bernstein Research | |
| 12.03.20 | UBS buy | UBS AG | |
| 11.03.20 | ams-OSRAM Underweight | Barclays Capital | |
| 11.03.20 | ams-OSRAM Underperform | Credit Suisse Group | |
| 11.03.20 | Novartis Equal-Weight | Morgan Stanley | |
| 11.03.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.03.20 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 10.03.20 | Nestlé Neutral | Credit Suisse Group | |
| 10.03.20 | UBS buy | Goldman Sachs Group Inc. | |
| 10.03.20 | Holcim overweight | Barclays Capital | |
| 10.03.20 | UBS buy | Goldman Sachs Group Inc. | |
| 09.03.20 | Roche overweight | JP Morgan Chase & Co. | |
| 09.03.20 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 09.03.20 | UBS overweight | JP Morgan Chase & Co. | |
| 09.03.20 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 06.03.20 | Holcim overweight | JP Morgan Chase & Co. | |
| 05.03.20 | Zurich Insurance buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.03.20 | UBS Neutral | JP Morgan Chase & Co. | |
| 04.03.20 | UBS overweight | JP Morgan Chase & Co. | |
| 04.03.20 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 03.03.20 | Roche overweight | Morgan Stanley | |
| 03.03.20 | ams-OSRAM Underweight | Barclays Capital |